Showing results (71-80 of 223) with videos related to
Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptorUdo Vanhoefer, Mitra Tewes, Federico Rojo, et al.Journal of Clinical Medicine|March 16, 2019
Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal CancerIon Cristóbal, Blanca Torrejón, Jaime Rubio, et al.American Journal of Cancer Research|December 2, 2016
Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell linesSandra Zazo, Paula González-Alonso, Ester Martín-Aparicio, et al.Cancer Research|May 21, 2010
ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cellsCarmen Casal, Antoni Xavier Torres-Collado, María Del Carmen Plaza-Calonge, et al.Journal of Clinical Medicine|March 25, 2022
CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast CancerMelani Luque, Ion Cristóbal, Marta Sanz-Álvarez, et al.Journal of Clinical Pathology|April 20, 2021
Molecular diagnosis in non-small-cell lung cancer: expert opinion on <i>ALK</i> and <i>ROS1</i> testingEsther Conde, Federico Rojo, Javier Gómez, et al.Journal of Clinical Medicine|August 1, 2020
MicroRNA-199b Deregulation Shows a Strong SET-Independent Prognostic Value in Early-Stage Colorectal CancerIon Cristóbal, Jaime Rubio, Blanca Torrejón, et al.Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|October 5, 2020
[Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Ramiro Álvarez-Alegret, Federico Rojo Todo, Pilar Garrido, et al.Global & Regional Health Technology Assessment|January 11, 2023
Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in SpainMargarita Majem, Rosa Álvarez, Ana Laura Ortega, et al.International Journal of Molecular Sciences|August 20, 2015
Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal LeiomyosarcomaPaula González-Alonso, Cristina Chamizo, Víctor Moreno, et al.Pageof 23